TP53 c.851_852delinsAC ;(p.T284N)

Variant ID: 17-7577086-TG-GT

NM_000546.5(TP53):c.851_852delinsAC;(p.T284N)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.

Nature Communications
Palanikumar, L L; Karpauskaite, Laura L; Al-Sayegh, Mohamed M; Chehade, Ibrahim I; Alam, Maheen M; Hassan, Sarah S; Maity, Debabrata D; Ali, Liaqat L; Kalmouni, Mona M; Hunashal, Yamanappa Y; Ahmed, Jemil J; Houhou, Tatiana T; Karapetyan, Shake S; Falls, Zackary Z; Samudrala, Ram R; Pasricha, Renu R; Esposito, Gennaro G; Afzal, Ahmed J AJ; Hamilton, Andrew D AD; Kumar, Sunil S; Magzoub, Mazin M
Publication Date: 2021-06-25

Variant appearance in text: p53: T284N
PubMed Link: 34172723
Variant Present in the following documents:
  • 41467_2021_23985_MOESM1_ESM.pdf
View BVdb publication page



Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response.

Breast Cancer (Dove Medical Press)
Jernström, Sandra S; Hongisto, Vesa V; Leivonen, Suvi-Katri SK; Due, Eldri Undlien EU; Tadele, Dagim Shiferaw DS; Edgren, Henrik H; Kallioniemi, Olli O; Perälä, Merja M; Mælandsmo, Gunhild Mari GM; Sahlberg, Kristine Kleivi KK
Publication Date: 2017

Variant appearance in text: TP53: T284N
PubMed Link: 28356768
Variant Present in the following documents:
  • Main text
  • bctt-9-185.pdf
View BVdb publication page